Two Sigma Advisers’s PRA Health Sciences, Inc. PRAH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | – | Sell |
-761,100
| Closed | -$126M | – | 2806 |
|
|
2021
Q2 | $126M | Buy |
761,100
+749,900
| +6,696% | +$125M | 0.33% | 68 |
|
|
2021
Q1 | $1.72M | Buy |
+11,200
| New | +$1.52M | ﹤0.01% | 1347 |
|
|
2020
Q4 | – | Sell |
-3,100
| Closed | -$314K | – | 2678 |
|
|
2020
Q3 | $314K | Buy |
+3,100
| New | +$316K | ﹤0.01% | 1995 |
|
|
2019
Q4 | – | Sell |
-7,900
| Closed | -$784K | – | 2520 |
|
|
2019
Q3 | $784K | Sell |
7,900
-44,200
| -85% | -$4.39M | ﹤0.01% | 1539 |
|
|
2019
Q2 | $5.17M | Buy |
52,100
+12,500
| +32% | +$1.19M | 0.01% | 819 |
|
|
2019
Q1 | $4.37M | Sell |
39,600
-7,900
| -17% | -$826K | 0.01% | 882 |
|
|
2018
Q4 | $4.37M | Sell |
47,500
-28,502
| -38% | -$2.88M | 0.01% | 850 |
|
|
2018
Q3 | $8.38M | Buy |
+76,002
| New | +$7.91M | 0.02% | 642 |
|
|
2018
Q2 | – | Sell |
-3,202
| Closed | -$266K | – | 2552 |
|
|
2018
Q1 | $266K | Sell |
3,202
-9,900
| -76% | -$880K | ﹤0.01% | 2058 |
|
|
2017
Q4 | $1.19M | Sell |
13,102
-263,100
| -95% | -$21.9M | ﹤0.01% | 1460 |
|
|
2017
Q3 | $21M | Buy |
276,202
+17,355
| +7% | +$1.31M | 0.06% | 350 |
|
|
2017
Q2 | $19.4M | Sell |
258,847
-110,455
| -30% | -$7.66M | 0.06% | 343 |
|
|
2017
Q1 | $24.1M | Buy |
369,302
+259,502
| +236% | +$15.3M | 0.08% | 320 |
|
|
2016
Q4 | $6.05M | Sell |
109,800
-16,516
| -13% | -$906K | 0.02% | 654 |
|
|
2016
Q3 | $7.14M | Buy |
+126,316
| New | +$6.19M | 0.03% | 519 |
|
|
2015
Q3 | – | Sell |
-11,100
| Closed | -$403K | – | 2054 |
|
|
2015
Q2 | $403K | Buy |
+11,100
| New | +$351K | ﹤0.01% | 1506 |
|
Other funds holding PRAH
Two Sigma Advisers's PRAH Position: Q3 2021 in Review
Two Sigma Advisers sold out of PRA Health Sciences, Inc. (PRAH) in Q3 2021, closing a stake of 761,100 shares — an estimated $126M sold.
Two Sigma Advisers first reported a position in PRAH in Q2 2015 and held it in 16 quarters. The position peaked at $126M in Q2 2021. 1 fund tracked by Wall St. Rank holds PRAH as of Q3 2021.
- Two Sigma Advisers reported no remaining PRA Health Sciences, Inc. position as of Q3 2021 after selling out during the quarter.
- Two Sigma Advisers sold 761,100 PRA Health Sciences, Inc. shares in Q3 2021, an estimated $126M.
- Two Sigma Advisers first reported a position in PRA Health Sciences, Inc. in Q2 2015 and held it in 16 quarters.
- Two Sigma Advisers's PRA Health Sciences, Inc. position peaked at $126M in Q2 2021.
- 1 fund tracked by Wall St. Rank held PRA Health Sciences, Inc. as of Q3 2021.
Based on Two Sigma Advisers's 13F filing for Q3 2021, filed 15 Nov 2021.